H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 199 Citations 313,337 605 World Ranking 64 National Ranking 10

Research.com Recognitions

Awards & Achievements

2005 - King Faisal Prize

2004 - Member of the National Academy of Medicine (NAM)

2002 - Charles S. Mott Prize, General Motors Cancer Research Foundation

2000 - Prince Mahidol Award

1992 - Canada Gairdner International Award

1989 - Fellow of the Royal Society, United Kingdom

Fellow of The Academy of Medical Sciences, United Kingdom

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Richard Peto focuses on Internal medicine, Surgery, Myocardial infarction, Breast cancer and Stroke. His Internal medicine study integrates concerns from other disciplines, such as Oncology and Cardiology. Richard Peto interconnects Rate ratio, Incidence and Cause of death in the investigation of issues within Surgery.

His Myocardial infarction research is multidisciplinary, relying on both Diabetes mellitus, Simvastatin, Placebo and Statin. His studies in Breast cancer integrate themes in fields like Relative risk, Gynecology, Radiation therapy and Chemotherapy. His Stroke research is multidisciplinary, incorporating elements of Aspirin, Physical therapy and Cholesterol.

His most cited work include:

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (14520 citations)
  • Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. (7672 citations)
  • Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. (7403 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Prospective cohort study, Surgery, Demography and Oncology. Blood pressure is closely connected to Cardiology in his research, which is encompassed under the umbrella topic of Internal medicine. Richard Peto has researched Prospective cohort study in several fields, including Body mass index, Epidemiology, Diabetes mellitus, Relative risk and Proportional hazards model.

Many of his studies on Surgery involve topics that are commonly interrelated, such as Clinical trial. His research integrates issues of Cause of death, Gerontology and China in his study of Demography. His Oncology research is multidisciplinary, incorporating perspectives in Tamoxifen, Chemotherapy and Early breast cancer.

He most often published in these fields:

  • Internal medicine (42.04%)
  • Prospective cohort study (16.92%)
  • Surgery (16.29%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (42.04%)
  • Prospective cohort study (16.92%)
  • Demography (12.81%)

In recent papers he was focusing on the following fields of study:

Richard Peto mainly focuses on Internal medicine, Prospective cohort study, Demography, Proportional hazards model and Diabetes mellitus. As part of his studies on Internal medicine, Richard Peto often connects relevant subjects like Oncology. His Prospective cohort study study combines topics in areas such as Incidence, Relative risk, Mortality rate, Hazard ratio and Pediatrics.

His research on Demography also deals with topics like

  • Body mass index together with Obesity,
  • Gerontology which intersects with area such as Cross-sectional study. While the research belongs to areas of Proportional hazards model, Richard Peto spends his time largely on the problem of Confidence interval, intersecting his research to questions surrounding Cause of death. Richard Peto has included themes like Vascular disease and Myocardial infarction in his Stroke study.

Between 2011 and 2021, his most popular works were:

  • Risk of Ischemic Heart Disease in Women After Radiotherapy for Breast Cancer (1940 citations)
  • Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. (1228 citations)
  • Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial (1150 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Internal medicine, Prospective cohort study, Demography, Stroke and Gerontology are his primary areas of study. His biological study spans a wide range of topics, including Surgery and Oncology. Richard Peto combines subjects such as Smoking cessation, Relative risk, Mortality rate, Cause of death and Proportional hazards model with his study of Prospective cohort study.

His Demography research incorporates elements of Substance abuse and Hazard ratio. His Stroke study incorporates themes from Diabetes mellitus, Cardiovascular disease in China, Family medicine, Vascular disease and Myocardial infarction. His study in Breast cancer is interdisciplinary in nature, drawing from both Radiation therapy and Disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner;R R Holman;C A Cull;I M Stratton.
The Lancet (1998)

31927 Citations

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Sarah Lewington;Robert Clarke;Nawab Qizilbash;Richard Peto.
The Lancet (2002)

14539 Citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

R Peto;M C Pike;P Armitage;N E Breslow.
British Journal of Cancer (1977)

11537 Citations

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

C Baigent;C Sudlow;R Collins;R Peto.
BMJ (2002)

11011 Citations

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

C Baigent;A Keech;P M Kearney;L Blackwell.
The Lancet (2005)

8646 Citations

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

Richard Doll;Richard Peto.
(1981)

8529 Citations

Mortality in relation to smoking: 50 years' observations on male British doctors

Richard Doll;Richard Peto;Jillian Boreham;Isabelle Sutherland.
BMJ (2004)

5953 Citations

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

R Altman;L Carreras;R Diaz;E Figueroa.
BMJ (1994)

5838 Citations

Tamoxifen for early breast cancer: An overview of the randomised trials

M Clarke;R Collins;C Davies.
The Lancet (1998)

5687 Citations

Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

S Macmahon;R Peto;J E Cutler;R Collins.
The Lancet (1990)

5670 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Richard Peto

Mark Woodward

Mark Woodward

George Institute for Global Health

Publications: 286

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 271

George Davey Smith

George Davey Smith

University of Bristol

Publications: 263

Paolo Boffetta

Paolo Boffetta

University of Bologna

Publications: 256

Carlo La Vecchia

Carlo La Vecchia

University of Milan

Publications: 255

Børge G. Nordestgaard

Børge G. Nordestgaard

Copenhagen University Hospital

Publications: 236

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 235

JoAnn E. Manson

JoAnn E. Manson

Harvard Medical School

Publications: 233

Julie E. Buring

Julie E. Buring

Brigham and Women's Hospital

Publications: 225

Christopher P. Cannon

Christopher P. Cannon

Brigham and Women's Hospital

Publications: 220

Meir J. Stampfer

Meir J. Stampfer

Harvard University

Publications: 217

Zhengming Chen

Zhengming Chen

University of Oxford

Publications: 202

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 190

Robert M. Califf

Robert M. Califf

Duke University

Publications: 189

Salim Yusuf

Salim Yusuf

McMaster University

Publications: 186

Something went wrong. Please try again later.